Press Releases Patient, Research, and Provider Groups File Amicus Brief Supporting FDA’s Rule on Laboratory Developed Tests November 4, 2024
Press Releases Medicare Could Save $14 Billion with Access to Ozempic and Wegovy Generics September 24, 2024
Press Releases Office of Inspector General at Department of Health and Human Services Should Investigate Conflict of Interest Allegations Against Senior FDA Official August 20, 2024
Press Releases First round of Medicare Drug Price Negotiations Promising Steps against Pharma Profiteering August 14, 2024
Press Releases FDA was Right to Decline Approval of MDMA-Assisted Therapy for PTSD and Encourage Further Research August 9, 2024
Press Releases Novo Nordisk’s $50 billion in Ozempic & Wegovy Sales Comes at the Expense of Healthcare Solvency August 7, 2024
Press Releases Public Citizen Urges HHS to Unlock Generic Competition for Popular Weight Loss Drugs Ozempic and Wegovy August 5, 2024
Press Releases FDA Fails Patients By Approving Flawed Alzheimer’s Disease Drug Donanemab (Kisunla) July 2, 2024